Skip to content
Search

Latest Stories

Study estimates autism affects one in 127 globally

The estimates come from the Global Burden of Diseases (GBD) Study, the largest and most comprehensive ones to assess health loss around the world over time

Study estimates autism affects one in 127 globally

The disorder is associated with repetitive behaviour and affected social skills.

(Photo for representation: iStock)

A STUDY has estimated that one in every 127 people globally, or 6.18 crore individuals, had autism in 2021, with the neurodevelopmental condition featuring among the top 10 causes of non-fatal health burden in youth aged under 20 years.

The disorder is associated with repetitive behaviour and affected social skills. Signs, which can begin to show as early as 12 months of age, include poor non-verbal communication, such as avoiding eye contact and not responding to their name.


Published in the Lancet Psychiatry journal, the results showed that globally, autism cases among men were over twice of those in women -- 1,065 cases for every 100,000 men and 508 for every 100,000 women.

The estimates come from the Global Burden of Diseases (GBD) Study, the largest and most comprehensive ones to assess health loss around the world over time, according to the Institute for Health Metrics and Evaluation, University of Washington, US, which coordinates it.

"An estimated 61.8 million individuals (one in every 127 people) were on the autism spectrum globally in 2021," the authors wrote.

Regions such as high-income Asia Pacific, including Japan, revealed the highest prevalence (1,560 per 100,000 population), while Tropical Latin America and Bangladesh reported the lowest, researchers said.

The findings underscored the importance of early detection and support to autistic young people and their caregivers globally, the authors said.

They also called for efforts to improve accuracy of the study's findings, including a better understanding of how autism prevalence differs with geography.

"The work presented here can guide future research efforts, and importantly, decisions concerning allocation of health services that better address the needs of all autistic individuals," the authors wrote.

(PTI)

More For You

menstruation

The findings come from a UK survey of more than 12,000 women

iStock

Heavier bleeding and iron loss linked to long Covid in women, study finds

Highlights:

  • Survey of more than 12,000 UK women finds heavier, longer periods linked to long Covid
  • Symptom severity rises and falls across the menstrual cycle, worsening during periods
  • Tests reveal inflammation in womb lining and hormonal changes, but no damage to ovaries
  • Iron deficiency risk may exacerbate fatigue, dizziness and other common long Covid symptoms

Study highlights link between long Covid and menstrual changes

Women with long Covid are more likely to experience longer and heavier periods, putting them at increased risk of iron deficiency, researchers have found. The findings come from a UK survey of more than 12,000 women, which also showed that the severity of long Covid symptoms fluctuated across the menstrual cycle and often worsened during menstruation.

Findings from UK survey

Between March and May 2021, 12,187 women completed an online survey. Of these, more than 1,000 had long Covid, over 1,700 had recovered from the virus, and 9,400 had never tested positive. The study revealed that women with long Covid reported heavier and longer periods, as well as more frequent bleeding between cycles, compared with other groups.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less